{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:46:04Z","timestamp":1773697564553,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.exphem.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T20:45:18Z","timestamp":1523565918000},"page":"52-63.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Synergistic action of dual IGF1\/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1"],"prefix":"10.1016","volume":"63","author":[{"given":"Victoria J.","family":"Weston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-6999","authenticated-orcid":false,"given":"Wenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.04.002_bib0001","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2008.1.366","article-title":"Molecular determinants of treatment response in acute lymphoblastic leukemia","author":"Campana","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2018.04.002_bib0002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.seminhematol.2008.09.001","article-title":"Minimal residual disease in acute lymphoblastic leukemia","volume":"46","author":"Campana","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0003","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.2009.07769.x","article-title":"The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97\/99","volume":"146","author":"Mitchell","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0004","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMoa1110169","article-title":"Outcomes after induction failure in childhood acute lymphoblastic leukemia","volume":"366","author":"Schrappe","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.04.002_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.2005.05572.x","article-title":"Outcome after first relapse in childhood acute lymphoblastic leukaemia: lessons from the United Kingdom R2 trial","volume":"130","author":"Roy","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0006","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.2000.01891.x","article-title":"The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study","volume":"108","author":"Lawson","year":"2000","journal-title":"Br J Haem"},{"key":"10.1016\/j.exphem.2018.04.002_bib0007","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukaemia: relapse study of the Berlin-Frankfurt-Munster Group 87","volume":"23","author":"Einsiedal","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0008","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjh.14474","article-title":"Genomic charactertization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics","volume":"176","author":"Tasian","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0009","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.04.002_bib0011","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","article-title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","volume":"98","author":"Schwab","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2018.04.002_bib0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/asheducation-2013.1.118","article-title":"Targeting signaling pathways in acute lymphoblastic leukemia: new insights","volume":"2013","author":"Harrison","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2018.04.002_bib0013","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.04.002_bib0014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2018.04.002_bib0015","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2018.04.002_bib0016","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","article-title":"Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"120","author":"Maude","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0017","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0018","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia","volume":"31","author":"Weston","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0019","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2012-09-456517","article-title":"Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia","volume":"120","author":"Eyre","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood-2003-11-4039","article-title":"Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling","volume":"104","author":"Weston","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood-2008-03-142950","article-title":"Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response","volume":"113","author":"Marston","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0022","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2018.04.002_bib0023","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2018.04.002_bib0024","doi-asserted-by":"crossref","first-page":"W755","DOI":"10.1093\/nar\/gkq405","article-title":"AltAnalyze and DomainGraph: analyzing and visualizing exon expression data","volume":"38","author":"Emig","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2018.04.002_bib0025","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0026","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/leu.2013.23","article-title":"C\/EBP\u03b1 and MYB regulate FLT3 expression in AML","volume":"27","author":"Volpe","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.002_bib0027","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/onc.2012.209","article-title":"Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions","volume":"32","author":"Couts","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2018.04.002_bib0028","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.yjmcc.2006.04.011","article-title":"Using U0126 to dissect the role of the extracellular signal-regulated kinase 1\/2 (ERK1\/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes","volume":"41","author":"Kennedy","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/rp.58.1.325","article-title":"Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression","volume":"58","author":"Dupont","year":"2003","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.exphem.2018.04.002_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/acel.12490","article-title":"Genomewise meta-analysis identified loci associated with IGF-1 and IGFBP-3 levels with impact on age-related traits","volume":"15","author":"Teumer","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.exphem.2018.04.002_bib0031","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2009.196","article-title":"The function of the pleckstrin homology domain in BCR\u2013ABL-mediated leukemogenesis","volume":"24","author":"Demehri","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.002_bib0032","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.1996.66052213.x","article-title":"Characterization of a novel platelet-derived growth factor-associated protein","volume":"66","author":"Fischer","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.exphem.2018.04.002_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biocel.2016.07.016","article-title":"Increased expression of platelet-derived growth factor associated protein-1 is associated with PDGF-B mediated glioma progression","volume":"78","author":"Sharma","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0034","doi-asserted-by":"crossref","first-page":"33939","DOI":"10.1074\/jbc.M109.009191","article-title":"Mediator of DNA damage checkpoint 1 (MDC1) regulates mitotic progression","volume":"284","author":"Townsend","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2018.04.002_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)81547-0","article-title":"The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder","volume":"99","author":"Stewart","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.04.002_bib0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.critrevonc.2005.08.005","article-title":"The role of constitutively active Stat6 in leukaemia in and lymphoma","volume":"57","author":"Bruns","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0037","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0038","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0039","doi-asserted-by":"crossref","unstructured":"Spina V, Bruscaggin A, Cuccaro A, et\u00a0al. Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma. Blood. 2018 [Epub ahead of print].","DOI":"10.1182\/blood-2017-11-812073"},{"key":"10.1016\/j.exphem.2018.04.002_bib0040","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood-2015-11-682906","article-title":"IL-4 enhances expression and function of surface IgM in CLL cells","volume":"127","author":"Aguilar-Hernandez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.002_bib0041","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2017.11.043","article-title":"Blocking interleukin (IL)4- and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects againstmacrophage-mediated radio-resistance of inflammatory breast cancer","volume":"100","author":"Rahal","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.exphem.2018.04.002_bib0042","first-page":"3","article-title":"Inhibition of STAT6\/Anoctamin-1 activation suppresses proliferation and invasion of gastric cancer cells","volume":"33","author":"Lu","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.exphem.2018.04.002_bib0043","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/oncsis.2017.23","article-title":"The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling","volume":"6","author":"Nappo","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.exphem.2018.04.002_bib0044","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9","article-title":"Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB","volume":"177","author":"Badache","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2018.04.002_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-003-0797-8","article-title":"Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors","volume":"107","author":"Holtkamp","year":"2004","journal-title":"Acta Neuropathol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18301711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18301711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:02Z","timestamp":1759566782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18301711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"alternative-id":["S0301472X18301711"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.04.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic action of dual IGF1\/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}